Skip to main
CME

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

CME Group reported a record revenue of $1.7 billion, reflecting a 10% year-over-year increase, which was supported by robust performance in Clearing & Transaction and Market Data revenue. The company experienced significant growth in international volumes, particularly in EMEA and APAC, with increases of 15% and 30% year-over-year, respectively, and added over 90,000 new retail traders, marking a 56% year-over-year rise. Additionally, CME's strategic positioning to benefit from rising interest rates and the anticipated earnings boost, coupled with strong demand for its capital efficiency offerings, underpins a positive outlook for the company.

Bears say

CME Group faces several challenges that contribute to a negative outlook on its stock. The potential for declining open interest (OI) signals a risk of deteriorating market sentiment and financial conditions, which could adversely affect trading volumes and, consequently, revenues. Additionally, increased regulatory scrutiny and the prospect of low market volatility further threaten the company's ability to maintain robust trading activity, ultimately impacting its financial performance given the interconnected nature of market volumes and CME's revenue model.

CME Group (CME) has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 12 analysts, CME Group (CME) has a Hold consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $286.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $286.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.